| Christine Ackroyd, NP | |
|
Lahey Clinic, 41 Mall Rd., Burlington, MA 01805-0001 | |
| (781) 744-8000 | |
| (781) 744-5261 |
| Full Name | Christine Ackroyd |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | Lahey Clinic, Burlington, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053693549 | NPI | - | NPPES |
| 110090336A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN265156 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Winchester Hospital | Winchester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lahey Clinic Inc | 2264336528 | 1211 |
News Archive
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
University of Texas Medical Branch researchers who helped assess the effectiveness of a new rapid test kit to diagnose Ebola learned this week it has received emergency use authorization from the Food and Drug Administration.
A comprehensive new study of irrigation in Asia warns that, without major reforms and innovations in the way water is used for agriculture, many developing nations face the politically risky prospect of having to import more than a quarter of the rice, wheat and maize they will need by 2050.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
› Verified 4 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
University of Texas Medical Branch researchers who helped assess the effectiveness of a new rapid test kit to diagnose Ebola learned this week it has received emergency use authorization from the Food and Drug Administration.
A comprehensive new study of irrigation in Asia warns that, without major reforms and innovations in the way water is used for agriculture, many developing nations face the politically risky prospect of having to import more than a quarter of the rice, wheat and maize they will need by 2050.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
› Verified 4 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
University of Texas Medical Branch researchers who helped assess the effectiveness of a new rapid test kit to diagnose Ebola learned this week it has received emergency use authorization from the Food and Drug Administration.
A comprehensive new study of irrigation in Asia warns that, without major reforms and innovations in the way water is used for agriculture, many developing nations face the politically risky prospect of having to import more than a quarter of the rice, wheat and maize they will need by 2050.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Ackroyd, NP Lahey Clinic, 41 Mall Rd., Burlington, MA 01805-0001 Ph: (781) 744-8460 | Christine Ackroyd, NP Lahey Clinic, 41 Mall Rd., Burlington, MA 01805-0001 Ph: (781) 744-8000 |
News Archive
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
University of Texas Medical Branch researchers who helped assess the effectiveness of a new rapid test kit to diagnose Ebola learned this week it has received emergency use authorization from the Food and Drug Administration.
A comprehensive new study of irrigation in Asia warns that, without major reforms and innovations in the way water is used for agriculture, many developing nations face the politically risky prospect of having to import more than a quarter of the rice, wheat and maize they will need by 2050.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
› Verified 4 days ago
Elaina Townsend, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-7000 | |
Mr. Joshua Bryan Dunn, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8000 | |
Marlene A Brady, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 20 Wall St, Burlington, MA 01803 Phone: 781-221-2600 Fax: 781-221-2510 | |
Thais Bitencourt Roberts, AGNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Deirdre Johanna Burke, NP, MPH Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 101 Cambridge St Ste 380, Burlington, MA 01803 Phone: 781-653-4281 | |
Corinne Prigo, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Nicole Annette Clarke Jagodowski, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 20 Wall St, Burlington, MA 01803 Phone: 781-221-2800 |